Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia - Abhishek Maiti; Courtney D. DiNardo; Naval G. Daver; Caitlin R. Rausch; Farhad Ravandi; Tapan M. Kadia; Naveen Pemmaraju; Gautam Borthakur; Prithviraj Bose; Ghayas C. Issa; Nicholas J. Short; Musa Yilmaz; et al. (Blood Cancer Journal, 2021)